|
CN111646998A
|
|
Synthesis method of ibrutinib
|
|
CN111617028A
|
|
Oral preparation containing ibrutinib and preparation method
|
|
CN111721936A
|
|
Method for detecting bacterial endotoxin in nalbuphine hydrochloride bulk drug
|
|
CN110261369A
|
|
The remaining measuring method of boron element in a kind of nalbuphlne hydrochloride bulk pharmaceutical chemicals
|
|
CN110200915A
|
|
A kind of Rupatadine fumarate emulsion-type nasal mist and preparation method thereof
|
|
CN110200939A
|
|
Ferroso-ferric oxide-soybean polyoses-sodium ozagrel composite nano materials preparation method
|
|
CN111116597A
|
|
Preparation method of nalbuphine free alkali
|
|
CN111110625A
|
|
Oral liquid preparation of rupatadine fumarate
|
|
CN108003139A
|
|
A kind of Rupatadine fumarate compound crystal and tablet
|
|
CN109400490A
|
|
A kind of preparation method of dapoxetine hydrochloride free alkali
|
|
CN108508117A
|
|
The related substance control method of Rupatadine fumarate piece
|
|
CN107778281A
|
|
One koji Ge Lieting process for purification
|
|
CN107550874A
|
|
A kind of Rupatadine fumarate tablet and preparation method thereof
|
|
CN106518758A
|
|
Preparation method of Betrixaban intermediate N-(5-chloro-2-pyridyl)-2-(4-cyanobenzeneformamido)-5-metoxybenzamide
|
|
CN106511312A
|
|
Compound sildennafil dapoxetine slow-release capsule and preparation method thereof
|
